ITBO20010271A0 - Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl - Google Patents

Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl

Info

Publication number
ITBO20010271A0
ITBO20010271A0 IT2001BO000271A ITBO20010271A ITBO20010271A0 IT BO20010271 A0 ITBO20010271 A0 IT BO20010271A0 IT 2001BO000271 A IT2001BO000271 A IT 2001BO000271A IT BO20010271 A ITBO20010271 A IT BO20010271A IT BO20010271 A0 ITBO20010271 A0 IT BO20010271A0
Authority
IT
Italy
Prior art keywords
neurotransission
alteration
disorders
prevention
treatment
Prior art date
Application number
IT2001BO000271A
Other languages
English (en)
Inventor
Giuseppe Cannazza
Carlo Parenti
Wolfgang Lindner
Giulia Puia
Mario Baraldi
Daniela Braghiroli
Annalisa Tait
Original Assignee
Giuseppe Cannazza
Carlo Parenti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuseppe Cannazza, Carlo Parenti filed Critical Giuseppe Cannazza
Priority to IT2001BO000271A priority Critical patent/ITBO20010271A1/it
Publication of ITBO20010271A0 publication Critical patent/ITBO20010271A0/it
Priority to EP02769353A priority patent/EP1435926A4/en
Priority to AU2002308614A priority patent/AU2002308614A1/en
Priority to PCT/US2002/014262 priority patent/WO2002089734A2/en
Publication of ITBO20010271A1 publication Critical patent/ITBO20010271A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2001BO000271A 2001-05-08 2001-05-08 Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl ITBO20010271A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT2001BO000271A ITBO20010271A1 (it) 2001-05-08 2001-05-08 Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl
EP02769353A EP1435926A4 (en) 2001-05-08 2002-05-07 METHODS OF TREATING AND PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS ASSOCIATED WITH ALTERATION OF GLUTAMATERGIC NEUROTRANSMISSION BY ADMINISTRATION OF 2-AMINOBENZENESULFONAMIDE DERIVATIVES
AU2002308614A AU2002308614A1 (en) 2001-05-08 2002-05-07 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives
PCT/US2002/014262 WO2002089734A2 (en) 2001-05-08 2002-05-07 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001BO000271A ITBO20010271A1 (it) 2001-05-08 2001-05-08 Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl

Publications (2)

Publication Number Publication Date
ITBO20010271A0 true ITBO20010271A0 (it) 2001-05-08
ITBO20010271A1 ITBO20010271A1 (it) 2002-11-08

Family

ID=11439316

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001BO000271A ITBO20010271A1 (it) 2001-05-08 2001-05-08 Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl

Country Status (4)

Country Link
EP (1) EP1435926A4 (it)
AU (1) AU2002308614A1 (it)
IT (1) ITBO20010271A1 (it)
WO (1) WO2002089734A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
WO2007076875A2 (en) * 2006-01-06 2007-07-12 Aarhus Universitet Compounds acting on the serotonin transporter
CA2915405A1 (en) 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
US6083947A (en) * 1996-01-29 2000-07-04 The Regents Of The University Of California Method for treating sexual dysfunctions
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
GB9818916D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use

Also Published As

Publication number Publication date
WO2002089734A2 (en) 2002-11-14
ITBO20010271A1 (it) 2002-11-08
WO2002089734A3 (en) 2003-03-06
AU2002308614A1 (en) 2002-11-18
EP1435926A4 (en) 2005-11-23
EP1435926A2 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
HK1152243A1 (en) Vegf for use in the treatment of central nervous system disorders vegf
DE60026996D1 (de) Plasmabehandlungsapparat, dessen elektrodenstruktur und struktur der bühne
NO20022585L (no) Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av forstyrrelser i sentralnervesystemet
NO20031903L (no) Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser
EE200100441A (et) Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
NO20023581D0 (no) Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
ZA200201161B (en) Methods of treating nuclear factor-kappa B mediated diseases and disorders.
MXPA03007960A (es) Compuestos y metodos para el tratamiento de desordenes urogenitales.
ZA200601973B (en) Methods and reagents for the treatment of immuno-inflammatory disorders
EE200200442A (et) Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20014950D0 (no) Nye behandlingsmetoder
PT1339406E (pt) Derivados de piperazina, sua preparacao e sua utilizacao para o tratamento de disturbios dos sistema nervoso central (snc)
BR0011210B1 (pt) mÉtodo e aparelho para esterilizaÇço com ozânio.
NO20031701D0 (no) Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener
ITMI20031104A0 (it) Acidi carbossilici per fluoropolirterei e loro uso per il trattamentooleorepellente della carta
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
ITBO20010271A0 (it) Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl
FR2829499B1 (fr) Procede de detection de micro-organismes et kit de detection
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
ATE286159T1 (de) Parallel-spinnprozess mit fadenverwirbelung zwischen galetten und spinnanlage hierzu
SG99371A1 (en) Hollow fiber membrane for the treatment of waste lubricants and method for its production
FR2824070B1 (fr) Procede de fabrication de vinaigre de biere et vinaigre de biere
AU2001235013A1 (en) Network-based method and apparatus for the detection of the dyslexia syndrome and related cvs disorders